{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:04:10Z","timestamp":1778126650017,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFE0103400"],"award-info":[{"award-number":["2017YFE0103400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microvascular Research"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.mvr.2021.104146","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T03:52:59Z","timestamp":1613879579000},"page":"104146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["CM082, a novel VEGF receptor tyrosine kinase inhibitor, can inhibit angiogenesis in vitro and in vivo"],"prefix":"10.1016","volume":"136","author":[{"given":"Handong","family":"Dan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinlan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqiao","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mvr.2021.104146_bb0005","article-title":"Retinal detachment after treatment of retinopathy of prematurity with laser versus intravitreal anti-vascular endothelial growth factor","author":"Barry","year":"2020","journal-title":"Ophthalmology."},{"key":"10.1016\/j.mvr.2021.104146_bb0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.survophthal.2017.08.008","article-title":"The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: a review","volume":"63","author":"Bracha","year":"2018","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.mvr.2021.104146_bb0020","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/nprot.2009.187","article-title":"Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis","volume":"4","author":"Connor","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.mvr.2021.104146_bb0025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2147\/CIA.S151225","article-title":"Clinical observations on the use of new anti-VEGF drug, conbercept, in age-related macular degeneration therapy: a meta-analysis","volume":"13","author":"Cui","year":"2018","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.mvr.2021.104146_bb0030","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3109\/02713683.2011.635916","article-title":"In vivo, in vitro toxicity and in vitro angiogenic inhibition of sunitinib malate","volume":"37","author":"Dib","year":"2012","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.mvr.2021.104146_bb0035","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2174\/1381612822666161216121105","article-title":"Hot topics in pharmacotherapy for neovascular age-related macular degeneration","volume":"23","author":"Falavarjani","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.mvr.2021.104146_bb0040","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2016.10.020","article-title":"Combined central retinal vein occlusion and central retinal arterial obstruction with cilioretinal artery sparing","volume":"124","author":"Gaier","year":"2017","journal-title":"Ophthalmology."},{"key":"10.1016\/j.mvr.2021.104146_bb0045","doi-asserted-by":"crossref","DOI":"10.1007\/s00417-020-05059-y","article-title":"Switching anti-VEGF agent for wet AMD: evaluation of impact on visual acuity, treatment frequency and retinal morphology in a real-world clinical setting","author":"Granstam","year":"2021","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.mvr.2021.104146_bb0050","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology."},{"key":"10.1016\/j.mvr.2021.104146_bb0055","first-page":"608","article-title":"Intravitreal aflibercept versus ranibizumab for wet age-related macular degeneration: a cost-effectiveness analysis","volume":"24","author":"Hernandez","year":"2018","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"10.1016\/j.mvr.2021.104146_bb0060","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10456-010-9184-y","article-title":"Moderate GSK-3beta inhibition improves neovascular architecture, reduces vascular leakage, and reduces retinal hypoxia in a model of ischemic retinopathy","volume":"13","author":"Hoang","year":"2010","journal-title":"Angiogenesis."},{"key":"10.1016\/j.mvr.2021.104146_bb0065","article-title":"Efficacy and safety of intravitreal Aflibercept injection in Japanese patients with neovascular glaucoma: outcomes from the VENERA study","author":"Inatani","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.mvr.2021.104146_bb0070","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jamaophthalmol.2017.1571","article-title":"Oral tyrosine kinase inhibitor for neovascular age-related macular degeneration: a phase 1 dose-escalation study","volume":"135","author":"Jackson","year":"2017","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.mvr.2021.104146_bb0075","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fchem.2019.00234","article-title":"Impedimetric biosensors for detecting vascular endothelial growth factor (VEGF) based on poly(3,4-ethylene dioxythiophene) (PEDOT)\/gold nanoparticle (Au NP) composites","volume":"7","author":"Kim","year":"2019","journal-title":"Front. Chem."},{"key":"10.1016\/j.mvr.2021.104146_bb0080","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1586\/17512433.2015.990379","article-title":"Current choice of treatments for neovascular AMD","volume":"8","author":"Lai","year":"2015","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.mvr.2021.104146_bb0085","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.ophtha.2014.03.026","article-title":"Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA study","volume":"121","author":"Li","year":"2014","journal-title":"Ophthalmology."},{"key":"10.1016\/j.mvr.2021.104146_bb0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nprot.2007.30","article-title":"In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro","volume":"2","author":"Liang","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.mvr.2021.104146_bb0095","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1016\/j.biomaterials.2010.01.104","article-title":"Biomimetic hydrogels with pro-angiogenic properties","volume":"31","author":"Moon","year":"2010","journal-title":"Biomaterials."},{"key":"10.1016\/j.mvr.2021.104146_bb0100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10456-004-3149-y","article-title":"The receptor tyrosine kinase inhibitor SU11248 impedes endothelial cell migration, tubule formation, and blood vessel formation in vivo, but has little effect on existing tumor vessels","volume":"7","author":"Osusky","year":"2004","journal-title":"Angiogenesis."},{"key":"10.1016\/j.mvr.2021.104146_bb0105","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.mvr.2018.08.002","article-title":"Anti-angiogenic effect of adiponectin in human primary microvascular and macrovascular endothelial cells","volume":"122","author":"Palanisamy","year":"2019","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.mvr.2021.104146_bb0110","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1158\/0008-5472.CAN-09-3201","article-title":"Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT\/mammalian target of rapamycin pathway","volume":"70","author":"Pang","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.mvr.2021.104146_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41433-020-01384-y","article-title":"Efficacy of bevacizumab for vitreous haemorrhage in proliferative diabetic retinopathy with prior complete panretinal photocoagulation","author":"Park","year":"2021","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.mvr.2021.104146_bb0120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ebiom.2017.12.014","article-title":"A vascular endothelial growth factor-dependent sprouting angiogenesis assay based on an in vitro human blood vessel model for the study of anti-angiogenic drugs","volume":"27","author":"Pauty","year":"2018","journal-title":"EBioMedicine."},{"key":"10.1016\/j.mvr.2021.104146_bb0125","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1021\/acs.molpharmaceut.5b00336","article-title":"Solubility challenges in high concentration monoclonal antibody formulations: relationship with amino acid sequence and intermolecular interactions","volume":"12","author":"Pindrus","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.mvr.2021.104146_bb0130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ajo.2016.02.028","article-title":"Postinjection endophthalmitis rates and characteristics following intravitreal bevacizumab, ranibizumab, and aflibercept","volume":"165","author":"Rayess","year":"2016","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.mvr.2021.104146_bb0135","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6145651","article-title":"The effect of CM082, an oral tyrosine kinase inhibitor, on experimental choroidal neovascularization in rats","volume":"2017","author":"Ren","year":"2017","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.mvr.2021.104146_bb0140","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/S0140-6736(11)61613-9","article-title":"Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial","volume":"378","author":"Rini","year":"2011","journal-title":"Lancet."},{"key":"10.1016\/j.mvr.2021.104146_bb0145","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/j.ophtha.2013.03.046","article-title":"Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP)","volume":"120","author":"Rofagha","year":"2013","journal-title":"Ophthalmology."},{"key":"10.1016\/j.mvr.2021.104146_bb0150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00280-018-3599-3","article-title":"Pharmacodynamic study using FLT PET\/CT in advanced solid malignancies treated with a sequential combination of X-82 and docetaxel","volume":"82","author":"Scarpelli","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.mvr.2021.104146_bb0155","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/bjophthalmol-2014-305702","article-title":"Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)","volume":"98","author":"Schmidt-Erfurth","year":"2014","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.mvr.2021.104146_bb0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jb\/mvs136","article-title":"Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases","volume":"153","author":"Shibuya","year":"2013","journal-title":"J. Biochem."},{"key":"10.1016\/j.mvr.2021.104146_bb0165","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/190486","article-title":"Vasculogenic cytokines in wound healing","volume":"2013","author":"Wong","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.mvr.2021.104146_bb0170","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/bjophthalmol-2018-313462","article-title":"Posterior segment drug delivery for the treatment of exudative age-related macular degeneration and diabetic macular oedema","volume":"103","author":"Wong","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.mvr.2021.104146_bb0175","article-title":"Endostar, a modified recombinant human endostatin, suppresses angiogenesis through inhibition of Wnt\/beta-catenin signaling pathway","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mvr.2021.104146_bb0180","doi-asserted-by":"crossref","first-page":"104103","DOI":"10.1016\/j.mvr.2020.104103","article-title":"Hepatocyte growth factor prevents pericyte loss in diabetic retinopathy","volume":"133","author":"Yun","year":"2021","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.mvr.2021.104146_bb0185","doi-asserted-by":"crossref","first-page":"104041","DOI":"10.1016\/j.mvr.2020.104041","article-title":"Selective induction of sprouting and intussusception is associated with the concentration distributions of oxygen and hypoxia-induced VEGF","volume":"132","author":"Zhan","year":"2020","journal-title":"Microvasc. Res."}],"container-title":["Microvascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286221000169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286221000169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T13:23:01Z","timestamp":1706016181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026286221000169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":36,"alternative-id":["S0026286221000169"],"URL":"https:\/\/doi.org\/10.1016\/j.mvr.2021.104146","relation":{},"ISSN":["0026-2862"],"issn-type":[{"value":"0026-2862","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CM082, a novel VEGF receptor tyrosine kinase inhibitor, can inhibit angiogenesis in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Microvascular Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mvr.2021.104146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104146"}}